Charlotte Hu and Lydia Ramsey / Business Insider: Finance
The rise and fall of Theranos, the blood-testing startup that went from a rising star in Silicon Val – Theranos star was shining bright going into 2015. The darling blood-testing startup had racked up a $9 billion valuation with its big vision to test for a number of conditions off just a small sample of blood, and its CEO Elizabeth Holmes was featured on the cover of business magazines …
